VisuALIF
Spinal Fusion
CommercialActive
Key Facts
About SpineSmith
SpineSmith operates at the intersection of medical device engineering and regenerative medicine, focusing on spinal pathologies. Its technology platform combines advanced manufacturing like 3D printing with biomaterials science to create implants designed to interface biologically with the human body. The company appears to be commercial-stage, offering products and is associated with Celling Biosciences, a pioneer in autologous cell therapy. It targets the large and growing market for spinal fusion and orthopedic biologics with a differentiated, biology-first approach.
View full company profileTherapeutic Areas
Other Spinal Fusion Drugs
| Drug | Company | Phase |
|---|---|---|
| JAZBI™ Cubes | SDIP Innovations | Preclinical |
| Expandable Interbody Portfolio | Globus Medical | Iterative Development |
| Mimetic Metal Technology Development | CoreLink Surgical | Development/Commercial |
| Bone Graft Substitute | BiologicsMD | Pre-clinical |
| ASTRO Registry | Artoss | Post-Market |
| Hive Smart Implant Exploration | NanoHive Medical | Pre-clinical R&D |
| ProLift Pivot Expandable Spacer System | Life Spine | FDA Cleared |
| NEXXT MATRIXX Clinical Evidence Study | Nexxt Spine | Post-Market Study |
| AGA111 | Angitia Biopharmaceuticals | Phase 3 |
| X-PAC® Portfolio Expansion | Expanding Innovations | Development |
| SOLACE™ | Xenix Medical | Commercial |
| TrellOss Porous Ti Interbody System | HighRidge Medical | Approved |